CL · ISSUER CIK 21665
COLGATE PALMOLIVE CO
Between Jul 31, 2026 and Oct 28, 2026, 12 COLGATE PALMOLIVE CO insiders reported $0.00 of open-market purchases and $31.0M of sales on SEC Form 4.
↗12 insiders filed
Original Form 4 filings from Jul 31, 2026 to Oct 28, 2026. 0 of 3 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$31.0MInsider selling
−$31.0MNet open-market
Oct 2, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 202616:06 | Oct 1, 2026 | CL | Director | A · Grant | $87.42 | +300 | 43,310 | +1% | $26K | ||
| Oct 2, 202616:05 | Oct 1, 2026 | CL | Director | A · Grant | $87.42 | +214 | 8,058 | +3% | $19K | ||
| Oct 2, 202616:05 | Oct 1, 2026 | CL | Director | A · Grant | $87.42 | +271 | 40,725 | +1% | $24K | ||
| Sep 18, 202616:10 | Sep 16, 2026 | CL | Chairman, President & CEO, Director | A · Grant | — | +29,649 | 379,700 | +8% | — | ||
| Sep 18, 202616:10 | Sep 16, 2026 | CL | COO, Americas | A · Grant | — | +7,355 | 79,503 | +10% | — | ||
| Sep 18, 202616:10 | Sep 16, 2026 | CL | COO, CD, EMEA, APac, Skin | A · Grant | — | +4,597 | 11,447 | +67% | — | ||
| Sep 18, 202616:09 | Sep 16, 2026 | CL | Chief Financial Officer | A · Grant | — | +8,045 | 79,029 | +11% | — | ||
| Sep 18, 202616:09 | Sep 16, 2026 | CL | Chief Growth Officer | A · Grant | — | +3,908 | 27,021 | +17% | — | ||
| Sep 18, 202616:09 | Sep 16, 2026 | CL | Chief People Officer | A · Grant | — | +3,333 | 15,397 | +28% | — | ||
| Sep 18, 202616:09 | Sep 16, 2026 | CL | CLO and Secretary | A · Grant | — | +2,207 | 16,050 | +16% | — | ||
| Sep 18, 202616:08 | Sep 16, 2026 | CL | EVP and Controller | A · Grant | — | +1,081 | 14,162 | +8% | — | ||
| Sep 15, 202616:11 | Sep 13, 2026from Sep 11, 2026 | CL | Chairman, President & CEO, Director | F · Tax | $86.80 | −12,479 | 350,051 | -3% | $1.1M | ||
| Sep 15, 202616:11 | Sep 13, 2026from Sep 11, 2026 | CL | COO, CD, EMEA, APac, Skin | F · Tax | $86.80 | −2,224 | 6,850 | -25% | $193K | ||
| Sep 15, 202616:11 | Sep 13, 2026from Sep 11, 2026 | CL | Chief Financial Officer | F · Tax | $86.80 | −3,509 | 70,984 | -5% | $305K | ||
| Sep 15, 202616:10 | Sep 13, 2026from Sep 11, 2026 | CL | Chief People Officer | F · Tax | $86.80 | −1,796 | 12,064 | -13% | $156K | ||
| Sep 15, 202616:10 | Sep 13, 2026from Sep 11, 2026 | CL | EVP and Controller | F · Tax | $86.80 | −543 | 13,081 | -4% | $47K | ||
| Sep 15, 202616:09 | Sep 13, 2026from Sep 11, 2026 | CL | Chief Growth Officer | F · Tax | $86.80 | −1,587 | 23,113 | -6% | $138K | ||
| Sep 15, 202616:09 | Sep 11, 2026 | CL | COO, Americas | F · Tax | $86.80 | −622 | 72,148 | -1% | $54K | ||
| Sep 15, 202616:08 | Sep 13, 2026from Sep 11, 2026 | CL | CLO and Secretary | F · Tax | $86.80 | −1,207 | 13,843 | -8% | $105K | ||
| Aug 26, 202616:47 | Aug 24, 2026 | CL | COO, CD, EMEA, APac, Skin | S · Sell | $92.05 | −10,000 | 64,901 | -13% | −$920K | ||
| Aug 7, 202617:23 | Aug 6, 2026 | CL | Director | S · Sell | $93.37 | −4,170 | 28,373 | -13% | −$389K | ||
| Aug 7, 202617:23 | Aug 6, 2026 | CL | Director | M · Exercise | $71.56 | +4,170 | 32,543 | +15% | $298K | ||
| Aug 6, 202616:27 | Aug 5, 2026from Aug 4, 2026 | CL | Chairman, President & CEO, Director | S · Sell | $92.22 | −322,042 | 362,231 | -47% | −$29.7M | ||
| Aug 6, 202616:27 | Aug 5, 2026from Aug 4, 2026 | CL | Chairman, President & CEO, Director | M · Exercise | $72.29 | +322,042 | 523,252 | +160% | $23.3M |